No, 10 mg of lorazepam IM is excessive and potentially dangerous for acute seizure treatment in a 214-lb patient.
The FDA-approved dose for lorazepam IM in status epilepticus is 0.05–0.10 mg/kg (maximum 4 mg per dose), which would be approximately 4.4–8.8 mg for this 97 kg patient, with a ceiling of 4 mg recommended. 1 A 10 mg dose exceeds both weight-based calculations and the established maximum single dose by 2.5-fold, significantly increasing the risk of respiratory depression, hypotension, and prolonged sedation without additional therapeutic benefit.
Correct Dosing for This Patient
For a 214-lb (97 kg) patient with acute seizure:
IV route (preferred): 4 mg given slowly at 2 mg/min 1
- May repeat once after 10-15 minutes if seizures continue
- Maximum total: 8 mg (two 4 mg doses)
IM route (only when IV unavailable): 0.05–0.10 mg/kg, maximum 4 mg 2, 1
- For this patient: approximately 5–10 mg by weight, but capped at 4 mg per FDA labeling
- IM is not preferred because therapeutic levels are reached more slowly than IV 1
Critical Safety Considerations
Respiratory depression is the primary concern with benzodiazepine overdosing. The evidence shows that while benzodiazepines themselves cause respiratory issues, the rate is actually lower than untreated status epilepticus 3. However, excessive dosing dramatically increases this risk without improving seizure control.
The pediatric guidelines specify maximum doses of 4 mg for lorazepam IV/IM in status epilepticus 2, and adult FDA labeling maintains this 4 mg ceiling for status epilepticus treatment 1. There is no evidence supporting doses above 4 mg per administration, and "experience with further doses of lorazepam is very limited" per FDA labeling 1.
Clinical Pitfalls to Avoid
Underdosing is common but overdosing is dangerous: Studies show 77-90% of patients receive inadequate benzodiazepine doses 4, 5, but the solution is proper weight-based dosing up to the maximum, not exceeding established limits
IM administration delays therapeutic effect: When IV access is available, always use it 1. IM lorazepam takes longer to reach therapeutic levels and is explicitly "not preferred" for status epilepticus 1
Equipment must be ready: Before administering any dose of lorazepam, have airway management equipment immediately available, including bag-valve-mask and intubation supplies 1. Monitor vital signs continuously and maintain IV access 2
If seizures persist after proper benzodiazepine dosing: Move to second-line agents (fosphenytoin, levetiracetam, or valproate) rather than exceeding benzodiazepine dose limits 6, 3
Proper Treatment Algorithm
- First-line: Lorazepam 4 mg IV at 2 mg/min (or 0.05–0.10 mg/kg IM if no IV, max 4 mg) 1
- Wait 10-15 minutes and observe 1
- If seizures continue: Repeat lorazepam 4 mg once 1
- If still seizing after two doses: Administer second-line ASM (fosphenytoin 20 mg PE/kg, levetiracetam 60 mg/kg, or valproate 40 mg/kg) 6, 3
- Refractory status epilepticus: Consider third-line agents (midazolam infusion, propofol, pentobarbital) with continuous EEG monitoring 7
The proposed 10 mg dose should be reduced to 4 mg maximum, administered via IV route if possible, with full airway management preparation.